Translate page

  • Presentations from the EHA2022 Congress

  • EHA 2022: Mechanisms of disease progression in chronic myeloid leukemia (S. Tiong Ong)

  • EHA 2022: Non-BCR-ABL1 biomarkers of prognosis in CML (Shady Awad)

  • COLT Meeting 2019: CML related topics

  • COLT Meeting 2019: The CML frontier

    November 2017 - With our mission to improve the outcomes for patients with CML globally, part of the iCMLf's mandate is to recognise and reward outstanding achievements and contributions to the management and understanding of CML around the world. GoldmanPrize medal RGB reducTo this end the iCMLf awards three prizes each year. We welcome your ideas and input to who should receive these prestigious awards in 2018. You can nominate for one, two or all of the prizes below:

    1. The Rowley Prize - recognising outstanding lifetime contribution to our understanding of the biology of CML. Previous winners: Brian Druker, Moshe Talpaz, John Goldman, George Q. Daley, Connie Eaves, Owen Witte, Rick Van Etten, Nora Heisterkamp with John Groffen and Tessa Holyoake.
    2. The Goldman Prize - recognising lifetime contributions to the management of patients with CML. Previous winners: Rüdiger Hehlmann, Michele Baccarani, Hagop Kantarjian and Tim Hughes. 
    3. The iCMLf Prize - recognising outstanding contributions to overcome the challenges of treating CML in the emerging regions. Previous winners: Pat Garcia-Gonzalez, Susan Branford and Jerald Radich. 

    Nominations for the 2018 iCMLf prizes are closed.